Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

PID Controller

PID Controller

Proportional-Integral-Derivative (PID) controllers are widely used in various control systems to enhance stability and performance. In a thermostat, it adjusts heating or cooling based on the temperature difference between the actual and desired levels. They are often used in automotive speed systems, effectively managing sudden speed changes while maintaining a constant speed under varying conditions. On the other hand, PI controllers, commonly employed in voltage regulation, enhance stability...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Early Stages of Automated Insulin Delivery.

Journal of diabetes science and technology·2025

Same author

Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.

Journal of diabetes science and technology·2025

Same author

Early Stages of Automated Insulin Delivery.

Diabetes technology & therapeutics·2025

Same author

Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.

Diabetes technology & therapeutics·2025

Same author

Accelerating pharmaceutical tablet development by transfer of powder compaction equipment across types and scales.

International journal of pharmaceutics·2024

Same author

Predicting drug solubility in organic solvents mixtures: A machine-learning approach supported by high-throughput experimentation.

International journal of pharmaceutics·2024

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

An improved PID switching control strategy for type 1 diabetes.

Gianni Marchetti¹, Massimiliano Barolo, Lois Jovanovic

¹Dipartimento di Principi e Impianti di Ingegneria Chimica, Università di Padova, 35131 Padova, Italy.

IEEE Transactions on Bio-Medical Engineering

|March 13, 2008

Summary

This study introduces an improved PID control strategy for artificial pancreas systems, enhancing blood glucose management. The novel approach demonstrates favorable performance in simulations under various realistic conditions.

Related Experiment Videos

Last Updated: Jul 6, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

Biomedical Engineering
Control Systems
Diabetes Technology

Background:

Developing a practical artificial pancreas requires robust closed-loop control strategies for ambulatory use.
Existing control methods face challenges with real-world variables like meal intake and sensor noise.

Purpose of the Study:

To propose and evaluate an improved Proportional-Integral-Derivative (PID) control strategy for blood glucose regulation in artificial pancreas systems.
To enhance the safety and efficacy of artificial pancreas technology through advanced control algorithms.

Main Methods:

In silico evaluation using the Hovorka et al. physiological model.
Implementation of a novel PID control strategy featuring meal-initiated switching, time-varying setpoints, and noise/derivative filters.
Assessment of controller tuning strategies for practical application.

Main Results:

The proposed PID control strategy demonstrated favorable performance compared to alternatives in simulations.
The strategy effectively managed blood glucose levels under realistic conditions, including meal challenges and sensor noise.
Key features like switching logic and filtering improved robustness and reduced sensitivity to disturbances.

Conclusions:

The improved PID control strategy offers a promising advancement for ambulatory artificial pancreas systems.
The validated control approach addresses critical challenges for real-world closed-loop blood glucose management.
Further development and clinical validation are warranted to translate these findings into practice.